Morocco - Healthcare, Regulatory And Reimbursement Landscape
Number of Pages: 140
Category: Pharmaceuticals
Country: Morocco
Format: PDF
Published Date: 09 Nov 2021
Morocco - Healthcare, Regulatory and Reimbursement Landscape
SummaryGlobalData, the industry analysis specialist, has released its latest report 'Morocco - Healthcare, Regulatory and Reimbursement Landscape'. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Morocco. It identifies the key trends in the country’s healthcare market and provides insights into its deamographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.Morocco is an emerging player in the global pharmaceutical market. In 2019, Moroccos pharmaceutical industry exported around 11% of national production to Europe, America, Asia, and Africa, indicating the importance of this industry, which is ranked second among the African continents after South Africa in terms of quality. In terms of Moroccan Dirhams, the country’s pharmaceutical market increased from MAD 9.31B in 2015 to MAD 13.83B in 2020, at a Compound Annual Growth Rate (CAGR) of 8.2%. In the terms of US dollars, the Moroccan pharmaceutical market increased from $1.02B in 2015 to $1.49B in 2020, at a CAGR of 6.5%. Morocco’s stable political environment and strategic location in the Mediterranean region, which connects Sub-Saharan Africa, the Middle East, and Europe, are intended to alleviate countrys pharmaceutical and healthcare industry in the next decade. The medical devices market in Morocco was valued at $270.2M in 2015, which decreased to $240.7M in 2020 at a negative CAGR of 2.3%. Morocco is progressively exploring to develop trade in medical devices and supplies with new partners, including Turkey, Brazil, Argentina, and several Far East countries, all of which can provide a similar quality of devices and supplies at lower costs. In 2018, the Moroccan Telemedicine Society (Société Marocaine de Télémédecine, SMT), in association with the Ministry of Health and Mohammed VI University of Health Sciences, launched a National Telemedicine Initiative with an aim to cover 160 rural municipalities and nearly 2 million population to create a significant health territory by 2025.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Morocco, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: GSK, Pfizer, Novartis, Sanofi, and Sothema
- Profiles and SWOT analyses of the major players in the medical device market: Roche Diagnostics, Abbott, Fresenius, Zimmer Biomet, and Air Liquide Healthcare
- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement landscape, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Moroccan healthcare market
Reasons to BuyThis report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Moroccan healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Moroccan healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
1
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about the Morocco Healthcare Market
2.3 Key Highlights: Healthcare Startups in Morocco
2.4 Key Events: Morocco Healthcare Industry, 2015-2021
2.5 Key Events: Morocco Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021
2.7 Key Events: Top Completed Deals by Value, 2020-2021
2.8 Country Profile, Morocco, 2020
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Morocco
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Morocco
3.7 COVID-19 Epidemiology, Morocco
3.8 COVID-19 Impact and Developments, Government response to mitigate the impact of COVID-19 Morocco
3.9 COVID-19 Impact and Developments in the Healthcare Market, Morocco
3.10 COVID-19 Clinical Trials Landscape, Morocco
3.11 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Morocco, 2019-2021
6.2 Deal Analysis: Medical Device Market, Morocco, 2020-2021
7. HealthTech Landscape
7.1 HealthTech Landscape, Morocco
7.2 HealthTech Deals Landscape, Morocco
7.3 Key HealthTech Deals, Morocco
7.4 Adoption of Technology in Healthcare, Morocco
7.5 Digital Health Regulations, Morocco
7.6 Digital Health: Benefits and Risks, Morocco
8. Market Access
8.1 Overview of Healthcare System, Morocco
8.2 Reimbursement Process, Morocco
8.3 Overview of Insurance Providers, Morocco
8.4 Out-of-Pocket Spending and Pharmaceutical Price Index, Morocco
8.5 Pricing Policies, Morocco
8.6 Regulatory Landscape, Morocco
8.6.1 Overview of Regulatory Agencies, Morocco
8.6.2 Marketing Authorization for Pharmaceutical Products, Morocco
8.6.3 Marketing Authorization for Biosimilars, Morocco
8.6.4 Marketing Authorization for Medical Devices, Morocco
8.6.5 Intellectual Property Rights, Patent, Morocco
8.6.6 Intellectual Property Rights, Trademark, Morocco
8.6.7 Clinical Trial Regulations, Morocco
8.6.8 Pharmaceutical Clinical Trials Landscape, Morocco
8.6.9 Medical Devices Clinical Trials Landscape, Morocco
8.6.10 Pharmacy License Regulations, Morocco
8.6.11 Pharmaceutical Advertising Regulations, Morocco
8.6.12 Labeling and Packaging Regulations, Morocco
9. Country Healthcare Landscape
9.1 Healthcare Policy Highlights, Morocco
9.2 Healthcare Facilities, Morocco
9.3 Life Expectancy and Immunization Rate, Morocco
9.4 Environmental Health, Morocco
9.5 Healthcare Personnel, Morocco
9.6 Disease Burden, Morocco
9.7 Healthcare Expenditure, Morocco
10. Trade Associations, Morocco
11. Trade Fairs, Morocco
12. Opportunities and Challenges
13. Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About GlobalData
13.4 Contact Us
13.5 Disclaimer